Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer

202051 citationsJournal Article

Authors

Good health and well-being

Published in: Gynecologic Oncology

Volume 159, Issue 1, pp. 142-149

Field-Weighted Citation Impact: 3.02